|
|
Volumn 7, Issue 4, 1997, Pages 390-406
|
|
Guidelines for diagnosis and management of osteoporosis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALENDRONIC ACID;
ANABOLIC AGENT;
BISPHOSPHONIC ACID DERIVATIVE;
CALCITONIN;
CALCIUM;
CLODRONIC ACID;
ESTROGEN;
ETIDRONIC ACID;
FLUORIDE SODIUM;
FLUOROPHOSPHATE;
IPRIFLAVONE;
PAMIDRONIC ACID;
PARATHYROID HORMONE;
PROGESTERONE;
RALOXIFENE;
TAMOXIFEN;
THIAZIDE DIURETIC AGENT;
TIBOLONE;
VITAMIN D DERIVATIVE;
BONE DENSITY;
BONE MINERAL;
BONE TURNOVER;
DENSITOMETRY;
DIARRHEA;
DIETARY INTAKE;
DUAL ENERGY X RAY ABSORPTIOMETRY;
FLUSHING;
GASTROINTESTINAL SYMPTOM;
HEALTH ECONOMICS;
HIP FRACTURE;
HOARSENESS;
HORMONE SUBSTITUTION;
HUMAN;
INTRANASAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
NAUSEA;
ORAL DRUG ADMINISTRATION;
OSTEOPOROSIS;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK FACTOR;
SHORT SURVEY;
SIDE EFFECT;
SUBCUTANEOUS DRUG ADMINISTRATION;
TRANSDERMAL DRUG ADMINISTRATION;
VOMITING;
ABSORPTIOMETRY, PHOTON;
BONE DENSITY;
DENSITOMETRY, X-RAY;
DIAGNOSIS, DIFFERENTIAL;
FEMALE;
FRACTURES, SPONTANEOUS;
HUMANS;
MALE;
MIDDLE AGED;
OSTEOPOROSIS;
OSTEOPOROSIS, POSTMENOPAUSAL;
PROGNOSIS;
RISK FACTORS;
|
|
EID: 0030873404
PISSN: 0937941X
EISSN: None
Source Type: Journal
DOI: 10.1007/BF01623782 Document Type: Short Survey |
|
Times cited : (760)
|
|
References (4)
|
